Boehringer Ingelheim Proprietary Ltd.

International Private company
78 Waterloo Rd., North Ryde,  NSW 2113, Australia
()61 02 8875 8800, 61 02 8875 8801 fax, http://www.boehringer-ingelheim.com

Primary SIC: Drugs, Proprietaries And Sundries, Primary NAICS: Drugs and Druggists' Sundries Merchant Wholesalers
Description: Wholesale: Wholesale trade in drugs and pharmaceutical

View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!

Boehringer Ingelheim Proprietary Ltd., News and Information

Xencor Appoints Former ZymoGenetics CEO, Bruce Carter, to Chairman of the Board.
Business Wire; 12/7/2009; 848 words; ...D. Searle & Co., Ltd. and was a Lecturer...continues to advance its proprietary products and build...biotherapeutics using its proprietary Protein Design Automation...Merck, Pfizer, CSL Ltd., Boehringer Ingelheim, and Human Genome...

Xencor Licenses Antibody Optimization Technology.
Business Wire; 11/30/2009; 1085 words; ...access to Xencor's proprietary Immunofilter...Life Xencor's proprietary antibody technology...molecules. Using its proprietary series of antibody...Merck, Pfizer, CSL Ltd., Boehringer Ingelheim, and Human Genome...

Xencor Appoints Jeffrey V. Ravetch of the Rockefeller University to its Scientific Advisory Board.
Clinical Trials Week; 9/14/2009; 1106 words; ...superior biotherapeutics using its proprietary Protein Design Automation...leaders Merck, Pfizer, CSL Ltd., Boehringer Ingelheim, MedImmune and Human Genome...Xencor is applying its suite of proprietary antibody Fc domains to improve...

Xencor Appoints Jeffrey V. Ravetch of The Rockefeller University to its Scientific Advisory Board.
Business Wire; 6/29/2009; 949 words; ...superior biotherapeutics using its proprietary Protein Design Automation...leaders Merck, Pfizer, CSL Ltd., Boehringer Ingelheim, MedImmune and Human Genome...Xencor is applying its suite of proprietary antibody Fc domains to improve...

Xencor Presents Preliminary Phase I Data on XmAb[R]2513 Antibody for Lymphomas at 2009 American Society of Clinical Oncology Annual Meeting.
Blood Weekly; 6/18/2009; 1579 words; ...developed from Xencor's proprietary antibody engineering...biotherapeutics using its proprietary Protein Design Automation...Merck, Pfizer, CSL Ltd., Boehringer Ingelheim, MedImmune and Human...applying its suite of proprietary antibody Fc domains...

Why Purchase This Company Profile?

  • Sales prospecting
  • Competitive analysis
  • Vendor & supplier evaluation
  • Customer evaluation and analysis
  • Strategic planning

Need More Information?

Start a new search

Tell Us What You Think

Take our short survey to tell us what would make Goliath more valuable to you.

Add Your Company Information to Goliath
If your company does not appear in Goliath, click here to add it.

Update Your Company Information
If your company information has changed or is not correct,
click here to let us know.